Jaap Rip
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
Papers in
- Biomaterials 13
- Nanoparticle-Based Drug Delivery 11
-
- Lipid metabolism and disorders 7
- Co-authors
- Pieter Jaap Gaillard (14 shared papers)Chantal C.M. Appeldoorn (6 shared papers)John J.P. Kastelein (13 shared papers)Jan Albert Kuivenhoven (12 shared papers)Arie Reijerkerk (4 shared papers)Margareta Hammarlund‐Udenaes (5 shared papers)Melchior C. Nierman (8 shared papers)Colin J. Ross (6 shared papers)
- Journals
- Arteriosclerosis Thrombosis and Vascular Biology (4 papers)Human Gene Therapy (4 papers)Journal of Controlled Release (3 papers)Drug Discovery Today Technologies (3 papers)Atherosclerosis (2 papers)
- Partner nations
- NetherlandsSwedenCanada
In The Last Decade
Jaap Rip
39 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 89
- Biomaterials 438
- Pharmaceutical Science 192
- Neurology 114
- Cardiology and Cardiovascular Medicine 240
- Endocrinology, Diabetes and Metabolism 156
Countries citing papers authored by Jaap Rip
This map shows the geographic impact of Jaap Rip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaap Rip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaap Rip more than expected).
Fields of papers citing papers by Jaap Rip
This network shows the impact of papers produced by Jaap Rip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaap Rip. The network helps show where Jaap Rip may publish in the future.
Co-authors
The 25 scholars most cited alongside Jaap Rip, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 166 | |
| 2 | 2014 | 136 | |
| 3 | 2006 | 135 | |
| 4 | 2015 | 134 | |
| 5 | 2012 | 89 | |
| 6 | 2009 | 85 | |
| 7 | 2016 | 77 | |
| 8 | 2004 | 66 | |
| 9 | 2005 | 60 | |
| 10 | 2005 | 57 | |
| 11 | 2005 | 53 | |
| 12 | 2015 | 49 | |
| 13 | 2011 | 40 | |
| 14 | 2017 | 38 | |
| 15 | 2016 | 35 | |
| 16 | 2005 | 23 | |
| 17 | 2014 | 23 | |
| 18 | 2018 | 22 | |
| 19 | 2005 | 21 | |
| 20 | 2013 | 19 |
About Jaap Rip
Jaap Rip is a scholar working on Biomaterials, Cardiology and Cardiovascular Medicine, Neurology, Oncology and Molecular Biology, having authored 39 papers that have together received 1.5k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (14 papers), Nanoparticle-Based Drug Delivery (11 papers), Lipid metabolism and disorders (7 papers), Diabetes and associated disorders (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Barrier Structure and Function Studies (4 papers) and Lipid Membrane Structure and Behavior (3 papers). The work is most often cited by research in Biomaterials (438 citations), Pharmaceutical Science (192 citations), Neurology (114 citations), Cardiology and Cardiovascular Medicine (240 citations) and Endocrinology, Diabetes and Metabolism (156 citations). Jaap Rip has collaborated with scholars based in Netherlands, Sweden and Canada. Frequent co-authors include Pieter Jaap Gaillard, Chantal C.M. Appeldoorn, John J.P. Kastelein, Jan Albert Kuivenhoven, Arie Reijerkerk, Margareta Hammarlund‐Udenaes, Melchior C. Nierman, Colin J. Ross, Michael R. Hayden and Geert J. Schenk. Their work appears in journals such as Arteriosclerosis Thrombosis and Vascular Biology, Human Gene Therapy, Journal of Controlled Release, Drug Discovery Today Technologies and Atherosclerosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.